NM_001033855.3:c.1893C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001033855.3(DCLRE1C):​c.1893C>T​(p.Pro631Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00556 in 1,614,068 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P631P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0044 ( 3 hom., cov: 31)
Exomes 𝑓: 0.0057 ( 29 hom. )

Consequence

DCLRE1C
NM_001033855.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.839

Publications

2 publications found
Variant links:
Genes affected
DCLRE1C (HGNC:17642): (DNA cross-link repair 1C) This gene encodes a nuclear protein that is involved in V(D)J recombination and DNA repair. The encoded protein has single-strand-specific 5'-3' exonuclease activity; it also exhibits endonuclease activity on 5' and 3' overhangs and hairpins. The protein also functions in the regulation of the cell cycle in response to DNA damage. Mutations in this gene can cause Athabascan-type severe combined immunodeficiency (SCIDA) and Omenn syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
DCLRE1C Gene-Disease associations (from GenCC):
  • Omenn syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Ambry Genetics
  • severe combined immunodeficiency due to DCLRE1C deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 10-14908594-G-A is Benign according to our data. Variant chr10-14908594-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137075.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.839 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00439 (668/152202) while in subpopulation NFE AF = 0.00629 (428/68016). AF 95% confidence interval is 0.0058. There are 3 homozygotes in GnomAd4. There are 310 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001033855.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DCLRE1C
NM_001033855.3
MANE Select
c.1893C>Tp.Pro631Pro
synonymous
Exon 14 of 14NP_001029027.1Q96SD1-1
DCLRE1C
NM_001289076.2
c.1548C>Tp.Pro516Pro
synonymous
Exon 12 of 12NP_001276005.1Q96SD1-3
DCLRE1C
NM_001289078.2
c.1548C>Tp.Pro516Pro
synonymous
Exon 12 of 12NP_001276007.1Q96SD1-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DCLRE1C
ENST00000378278.7
TSL:1 MANE Select
c.1893C>Tp.Pro631Pro
synonymous
Exon 14 of 14ENSP00000367527.2Q96SD1-1
DCLRE1C
ENST00000378289.8
TSL:1
c.1157-9282C>T
intron
N/AENSP00000367538.4Q96SD1-4
DCLRE1C
ENST00000357717.6
TSL:1
n.*1551C>T
non_coding_transcript_exon
Exon 12 of 12ENSP00000350349.3A0A9S7JGJ5

Frequencies

GnomAD3 genomes
AF:
0.00437
AC:
665
AN:
152084
Hom.:
3
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00570
Gnomad ASJ
AF:
0.00606
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00125
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00628
Gnomad OTH
AF:
0.0101
GnomAD2 exomes
AF:
0.00375
AC:
942
AN:
251202
AF XY:
0.00355
show subpopulations
Gnomad AFR exome
AF:
0.00283
Gnomad AMR exome
AF:
0.00332
Gnomad ASJ exome
AF:
0.00566
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00555
Gnomad OTH exome
AF:
0.00441
GnomAD4 exome
AF:
0.00568
AC:
8299
AN:
1461866
Hom.:
29
Cov.:
32
AF XY:
0.00550
AC XY:
4002
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00305
AC:
102
AN:
33478
American (AMR)
AF:
0.00340
AC:
152
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00559
AC:
146
AN:
26132
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39690
South Asian (SAS)
AF:
0.00176
AC:
152
AN:
86256
European-Finnish (FIN)
AF:
0.000449
AC:
24
AN:
53420
Middle Eastern (MID)
AF:
0.00173
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
0.00665
AC:
7396
AN:
1112004
Other (OTH)
AF:
0.00520
AC:
314
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
477
955
1432
1910
2387
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00439
AC:
668
AN:
152202
Hom.:
3
Cov.:
31
AF XY:
0.00417
AC XY:
310
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.00248
AC:
103
AN:
41532
American (AMR)
AF:
0.00569
AC:
87
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00606
AC:
21
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00125
AC:
6
AN:
4814
European-Finnish (FIN)
AF:
0.000189
AC:
2
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00629
AC:
428
AN:
68016
Other (OTH)
AF:
0.00995
AC:
21
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
34
68
101
135
169
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00508
Hom.:
2
Bravo
AF:
0.00472
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00581

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
-
2
Histiocytic medullary reticulosis (2)
-
-
1
Severe combined immunodeficiency due to DCLRE1C deficiency (1)
-
-
1
Severe combined immunodeficiency due to DCLRE1C deficiency;C2700553:Histiocytic medullary reticulosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.0
DANN
Benign
0.52
PhyloP100
0.84
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41300676; hg19: chr10-14950593; API